NCT05298592 2024-09-26
A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors
Bristol-Myers Squibb
Phase 1 Completed
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Eli Lilly and Company
Eli Lilly and Company